§516.28. Publication of MUMS-drug designations.
21 C.F.R. § 516.28
FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Dockets Management Staff, and will contain the following information for each MUMS-designated drug:
The name and address of the sponsor;
The established name and trade name, if any, of the drug;
The dosage form of the drug;
The species and the proposed intended use for which MUMS-drug designation was granted; and
The date designation was granted.
Notes, amendments, and revision history
Amendments
[72 FR 41017, July 26, 2007, as amended at 88 FR 45066, July 14, 2023]
Authority
Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371.
Source
Source: 72 FR 41017, July 26, 2007, unless otherwise noted.
Amendments
[72 FR 41017, July 26, 2007, as amended at 88 FR 45066, July 14, 2023]